Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Xinyu Xiang

Parker Scholar

Early Career Researcher

Biography

Parker Scholar Xinyu Xiang of Stanford Medicine is developing a new platform to generate T cell receptor mimetics that can recognize tumor-associated peptide-MHC complexes with high specificity. Her project will combine protein engineering, synthetic co-evolution, and machine learning to systematically discover new binders and expand the range of cancer targets that can be recognized by targeted immunotherapies.